Prime Medicine, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Prime Medicine, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Prime Medicine, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $49.4M, a 186% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $49.4M +$32.1M +186% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $51.6M +$25.1M +94.7% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $55.5M +$28.8M +108% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $13.9M -$15.6M -52.8% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $17.3M -$15.1M -46.6% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $26.5M Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $26.7M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $29.5M +$18.8M +175% Dec 31, 2022 10-K 2024-03-01
Q3 2022 $32.3M Sep 30, 2022 10-Q 2022-11-14
Q4 2021 $10.7M +$7.95M +284% Dec 31, 2021 10-K 2023-03-09
Q4 2020 $2.8M Jan 1, 2021 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.